There will be a CC at the end of Aug - we should get a better understanding on next steps in a few weeks time.
Anyway for what it worth, The LBP and CHF is where the money is.
Both trials have been perfectly run to FDA standard, so the sooner they get it going the better, my guess is AA for CHF, and a successful 4th trial for LBP.
As for AGVHD unless they get AA for the under 12's and a fully funded academic study, I think it will be mothballed for another day.
Can someone confirm if both Rex and Rem are made at the same facility in Singapore?
There will be a CC at the end of Aug - we should get a better...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.020(1.91%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.07 | $1.04 | $4.010M | 3.797M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 67587 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 45960 | 7 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.07 |
Change
0.020 ( 2.55 %) |
||||
| Open | High | Low | Volume | ||
| $1.04 | $1.07 | $1.04 | 699949 | ||
| Last updated 15.59pm 14/05/2024 ? | |||||
| MSB (ASX) Chart |